Pacific Biosciences of California, Inc. stock is up 42.39% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 64.29% of the previous 13 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 75% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
16 Nov 19:16 | 19 Jan, 2024 | 8.00 | 8256 | ||
17 Nov 20:36 | 15 Dec, 2023 | 8.00 | 795 | ||
17 Nov 20:38 | 15 Dec, 2023 | 9.00 | 1185 | ||
20 Nov 18:03 | 19 Jan, 2024 | 9.00 | 423 | ||
20 Nov 20:35 | 15 Dec, 2023 | 7.00 | 251 | ||
21 Nov 16:11 | 19 Jan, 2024 | 7.00 | 152 | ||
21 Nov 20:08 | 19 Jan, 2024 | 7.00 | 152 | ||
22 Nov 19:24 | 19 Jan, 2024 | 8.00 | 9119 | ||
28 Nov 17:12 | 15 Dec, 2023 | 8.00 | 142 | ||
29 Nov 20:33 | 15 Dec, 2023 | 7.00 | 421 |
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. PacBio's Systems conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow.